Stress Among Final Year BAMS Students in Relation With Covid Lockdown Through CSSQ-a Cross Sectional Survey

February 14, 2022 updated by: Dr.Preethi Mohan, Amrita Vishwa Vidyapeetham

Covid -19 Related Stress Among Final Year BAMS Students During Lock Down Days in Kerala-A Cross Sectional Study

We were randomly selected the ayurveda colleges in Kerala.Selected final year BAMS students as participants.we have also selected a group of 5 members for data colle tion.we have selected a validated Covid stress questionnaire and circulated through what's app and Gmail.we were received responses from each college with .we analyzed and interpreted data.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

We were randomly selected the ayurveda colleges in Kerala.Selected final year BAMS students as participants.we have also selected a group of 5 members for data colle tion.we have selected a validated Covid stress questionnaire and circulated through what's app and Gmail.we were received responses from each college with .we analyzed and interpreted data.

Study Type

Observational

Enrollment (Actual)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kerala
      • Kollam, Kerala, India, 690525
        • Dr Preeti

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 22 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

All final year students Of BAMS studying inside Kerala.

Description

Inclusion Criteria 1.final year BAMS 2.irrespective of gender

-

Exclusion Criteria:

  • age group other than 20-22 yrs

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Likert scale
Time Frame: 10 days
4 point likert scale questionnaire
10 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dr.preethi Mohan, BAMS MD, Amrita Viswa Vidyapeetham
  • Principal Investigator: Delvin T Robin, Amrita Vishwa Vidyapeetham

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 30, 2021

Primary Completion (Actual)

December 10, 2021

Study Completion (Actual)

December 10, 2021

Study Registration Dates

First Submitted

February 14, 2022

First Submitted That Met QC Criteria

February 14, 2022

First Posted (Actual)

February 15, 2022

Study Record Updates

Last Update Posted (Actual)

February 15, 2022

Last Update Submitted That Met QC Criteria

February 14, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Not yet assaigned

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe